Skip to main content
Top
Published in: Malaria Journal 1/2010

Open Access 01-12-2010 | Research

Evaluation of medication adherence methods in the treatment of malaria in Rwandan infants

Authors: Marc Twagirumukiza, Pierre Claver Kayumba, Jan G Kips, Bernard Vrijens, Robert Vander Stichele, Chris Vervaet, Jean Paul Remon, M Luc Van Bortel

Published in: Malaria Journal | Issue 1/2010

Login to get access

Abstract

Objectives

To compare three methods for evaluating treatment adherence in a 7-day controlled treatment period for malaria in children in Rwanda.

Methods

Fifty-six children (< 5 years) with malaria were recruited at the University Hospital of Butare, Rwanda. Patients were treated with quinine sulfate, taste-masked, pellets during seven days: three days in hospital (in-patient) followed by a four-day out-patient period. Three methods to evaluate medication adherence among patients were compared: manual pill count of returned tablets, patient self-report and electronic pill-box monitoring. These pill-boxes were equipped with a microchip registering date and time of every opening. Medication adherence was defined as the proportion of prescribed doses taken. The inter-dose intervals were analysed as well.

Results

Medication adherence data were available for 54 of the 56 patients. Manual pill count and patient self-report yielded a medication adherence of 100% for the in- and out-patient treatment periods. Based on electronic pill-box monitoring, medication adherence during the seven-day treatment period was 90.5 ± 8.3%. Based on electronic pill-box monitoring inpatient medication adherence (99.3 ± 2.7%) was markedly higher (p < 0.03) than out-patient adherence (82.7 ± 14.7%), showing a clear difference between health workers' and consumers' medication adherence.

Conclusion

Health workers' medication adherence was good. However, a significant lower medication adherence was observed for consumers' adherence in the outpatient setting. This was only detected by electronic pill-box monitoring. Therefore, this latter method is more accurate than the two other methods used in this study.
Appendix
Available only for authorised users
Literature
2.
go back to reference WHO: Guidelines for the treatment of malaria. 2010, Geneva: World Health Organization, Second WHO: Guidelines for the treatment of malaria. 2010, Geneva: World Health Organization, Second
3.
go back to reference Cramer JA: Practical issues in medication compliance. Transplant Proc. 1999, 31: 7S-9S. 10.1016/S0041-1345(99)00112-8.CrossRefPubMed Cramer JA: Practical issues in medication compliance. Transplant Proc. 1999, 31: 7S-9S. 10.1016/S0041-1345(99)00112-8.CrossRefPubMed
4.
go back to reference De Klerk E: Measurement of patient compliance on drug therapy: an overview. Advances in behavioral medicine assesment. Edited by: Vingerhoets A. 2001, Harwood academic Publishers De Klerk E: Measurement of patient compliance on drug therapy: an overview. Advances in behavioral medicine assesment. Edited by: Vingerhoets A. 2001, Harwood academic Publishers
5.
go back to reference Depoortere E, Guthmann JP, Sipilanyambe N, Nkandu E, Fermon F, Balkan S, Legros D: Adherence to the combination of sulphadoxine-pyrimethamine and artesunate in the Maheba refugee settlement, Zambia. Trop Med Int Health. 2004, 9: 62-67. 10.1046/j.1365-3156.2003.01157.x.CrossRefPubMed Depoortere E, Guthmann JP, Sipilanyambe N, Nkandu E, Fermon F, Balkan S, Legros D: Adherence to the combination of sulphadoxine-pyrimethamine and artesunate in the Maheba refugee settlement, Zambia. Trop Med Int Health. 2004, 9: 62-67. 10.1046/j.1365-3156.2003.01157.x.CrossRefPubMed
6.
go back to reference Kachur SP, Khatib RA, Kaizer E, Fox SS, Abdulla SM, Bloland PB: Adherence to antimalarial combination therapy with sulfadoxine-pyrimethamine and artesunate in rural Tanzania. Am J Trop Med Hyg. 2004, 71: 715-722.PubMed Kachur SP, Khatib RA, Kaizer E, Fox SS, Abdulla SM, Bloland PB: Adherence to antimalarial combination therapy with sulfadoxine-pyrimethamine and artesunate in rural Tanzania. Am J Trop Med Hyg. 2004, 71: 715-722.PubMed
7.
go back to reference Rudd P: In search of the gold standard for compliance measurement. Arch Intern Med. 1979, 139: 627-628. 10.1001/archinte.139.6.627.CrossRefPubMed Rudd P: In search of the gold standard for compliance measurement. Arch Intern Med. 1979, 139: 627-628. 10.1001/archinte.139.6.627.CrossRefPubMed
8.
go back to reference Wetzels G, Nelemans P, van WB, Broers N, Schouten J, Prins M: Determinants of poor adherence in hypertensive patients: development and validation of the "Maastricht Utrecht Adherence in Hypertension (MUAH)-questionnaire". Patient Educ Couns. 2006, 64: 151-158. 10.1016/j.pec.2005.12.010.CrossRefPubMed Wetzels G, Nelemans P, van WB, Broers N, Schouten J, Prins M: Determinants of poor adherence in hypertensive patients: development and validation of the "Maastricht Utrecht Adherence in Hypertension (MUAH)-questionnaire". Patient Educ Couns. 2006, 64: 151-158. 10.1016/j.pec.2005.12.010.CrossRefPubMed
9.
go back to reference Rosen MI, Rigsby MO, Salahi JT, Ryan CE, Cramer JA: Electronic monitoring and counseling to improve medication adherence. Behaviour Research and Therapy. 2004, 42: 409-422. 10.1016/S0005-7967(03)00149-9.CrossRefPubMed Rosen MI, Rigsby MO, Salahi JT, Ryan CE, Cramer JA: Electronic monitoring and counseling to improve medication adherence. Behaviour Research and Therapy. 2004, 42: 409-422. 10.1016/S0005-7967(03)00149-9.CrossRefPubMed
10.
go back to reference Wetzels GE, Nelemans PJ, Schouten JS, Dirksen CD, van der WT, Stoffers HE, Janknegt R, de Leeuw PW, Prins MH: Electronic monitoring of adherence as a tool to improve blood pressure control a randomized controlled trial. Am J Hypertens. 2007, 20: 119-125. 10.1016/j.amjhyper.2006.07.018.CrossRefPubMed Wetzels GE, Nelemans PJ, Schouten JS, Dirksen CD, van der WT, Stoffers HE, Janknegt R, de Leeuw PW, Prins MH: Electronic monitoring of adherence as a tool to improve blood pressure control a randomized controlled trial. Am J Hypertens. 2007, 20: 119-125. 10.1016/j.amjhyper.2006.07.018.CrossRefPubMed
11.
go back to reference Choo PW, Rand CS, Inui TS, Lee ML, Cain E, Cordeiro-Breault M, Canning C, Platt R: Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care. 1999, 37: 846-857. 10.1097/00005650-199909000-00002.CrossRefPubMed Choo PW, Rand CS, Inui TS, Lee ML, Cain E, Cordeiro-Breault M, Canning C, Platt R: Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care. 1999, 37: 846-857. 10.1097/00005650-199909000-00002.CrossRefPubMed
12.
go back to reference Diaz E, Levine H, Sullivan MC, Sernyak MJ, Hawkins KA, Cramer JA, Woods SW: Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia. J Psychiatry Neurosci. 2001, 26: 325-329.PubMedCentralPubMed Diaz E, Levine H, Sullivan MC, Sernyak MJ, Hawkins KA, Cramer JA, Woods SW: Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia. J Psychiatry Neurosci. 2001, 26: 325-329.PubMedCentralPubMed
13.
go back to reference Hugen PW, Langebeek N, Burger DM, Zomer B, van LR, Schuurman R, Koopmans PP, Hekster YA: Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring. J Acquir Immune Defic Syndr. 2002, 30: 324-334.CrossRefPubMed Hugen PW, Langebeek N, Burger DM, Zomer B, van LR, Schuurman R, Koopmans PP, Hekster YA: Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring. J Acquir Immune Defic Syndr. 2002, 30: 324-334.CrossRefPubMed
14.
go back to reference Lee JY, Kusek JW, Greene PG, Bernhard S, Norris K, Smith D, Wilkening B, Wright JT: Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Am J Hypertens. 1996, 9: 719-725. 10.1016/0895-7061(96)00056-8.CrossRefPubMed Lee JY, Kusek JW, Greene PG, Bernhard S, Norris K, Smith D, Wilkening B, Wright JT: Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Am J Hypertens. 1996, 9: 719-725. 10.1016/0895-7061(96)00056-8.CrossRefPubMed
15.
go back to reference Mallion JM, Dutrey-Dupagne C, Vaur L, Genes N, Renault M, Elkik F, Baguet P, Boutelant S: Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension. J Hypertens. 1996, 14: 137-144.PubMed Mallion JM, Dutrey-Dupagne C, Vaur L, Genes N, Renault M, Elkik F, Baguet P, Boutelant S: Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension. J Hypertens. 1996, 14: 137-144.PubMed
16.
go back to reference Bell DJ, Wootton D, Mukaka M, Montgomery J, Kayange N, Chimpeni P, Hughes DA, Molyneux ME, Ward SA, Winstanley PA, Lalloo DG: Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi. Malar J. 2009, 8: 204-10.1186/1475-2875-8-204.PubMedCentralCrossRefPubMed Bell DJ, Wootton D, Mukaka M, Montgomery J, Kayange N, Chimpeni P, Hughes DA, Molyneux ME, Ward SA, Winstanley PA, Lalloo DG: Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi. Malar J. 2009, 8: 204-10.1186/1475-2875-8-204.PubMedCentralCrossRefPubMed
17.
go back to reference Kayumba PC, Twagirumukiza M, Huyghebaert N, Ntawukuliryayo JD, Van Bortel L, Vervaet C, Remon JP: Taste-masked quinine sulphate pellets: bio-availability in adults and steady-state plasma concentrations in children with uncomplicated Plasmodium falciparum malaria. Ann Trop Paed. 2008, 28: 103-109. 10.1179/146532808X302116.CrossRef Kayumba PC, Twagirumukiza M, Huyghebaert N, Ntawukuliryayo JD, Van Bortel L, Vervaet C, Remon JP: Taste-masked quinine sulphate pellets: bio-availability in adults and steady-state plasma concentrations in children with uncomplicated Plasmodium falciparum malaria. Ann Trop Paed. 2008, 28: 103-109. 10.1179/146532808X302116.CrossRef
18.
go back to reference World Health Organization: Monitoring antimalarial drug rsistance: Report of WHO consultation. 2001, Geneva: WHO World Health Organization: Monitoring antimalarial drug rsistance: Report of WHO consultation. 2001, Geneva: WHO
19.
go back to reference Souares A, Lalou R, Sene I, Sow D, Le Hesran JY: Factors related to compliance to anti-malarial drug combination: example of amodiaquine/sulphadoxine-pyrimethamine among children in rural Senegal. Malar J. 2009, 8: 118-10.1186/1475-2875-8-118.PubMedCentralCrossRefPubMed Souares A, Lalou R, Sene I, Sow D, Le Hesran JY: Factors related to compliance to anti-malarial drug combination: example of amodiaquine/sulphadoxine-pyrimethamine among children in rural Senegal. Malar J. 2009, 8: 118-10.1186/1475-2875-8-118.PubMedCentralCrossRefPubMed
20.
go back to reference Nshakira N, Kristensen M, Ssali F, Whyte SR: Appropriate treatment of malaria? Use of antimalarial drugs for children's fevers in district medical units, drug shops and homes in eastern Uganda. Trop Med Int Health. 2002, 7: 309-316. 10.1046/j.1365-3156.2002.00858.x.CrossRefPubMed Nshakira N, Kristensen M, Ssali F, Whyte SR: Appropriate treatment of malaria? Use of antimalarial drugs for children's fevers in district medical units, drug shops and homes in eastern Uganda. Trop Med Int Health. 2002, 7: 309-316. 10.1046/j.1365-3156.2002.00858.x.CrossRefPubMed
21.
go back to reference Fogg C, Bajunirwe F, Piola P, Biraro S, Checchi F, Kiguli J, Namiiro P, Musabe J, Kyomugisha A, Guthmann JP: Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda. Am J Trop Med Hyg. 2004, 71: 525-530.PubMed Fogg C, Bajunirwe F, Piola P, Biraro S, Checchi F, Kiguli J, Namiiro P, Musabe J, Kyomugisha A, Guthmann JP: Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda. Am J Trop Med Hyg. 2004, 71: 525-530.PubMed
22.
go back to reference Namkoong K, Farren CK, O'Connor PG, O'Malley SS: Measurement of compliance with naltrexone in the treatment of alcohol dependence: research and clinical implications. J Clin Psychiatry. 1999, 60: 449-453. 10.4088/JCP.v60n0706.CrossRefPubMed Namkoong K, Farren CK, O'Connor PG, O'Malley SS: Measurement of compliance with naltrexone in the treatment of alcohol dependence: research and clinical implications. J Clin Psychiatry. 1999, 60: 449-453. 10.4088/JCP.v60n0706.CrossRefPubMed
23.
go back to reference Jeffrey HS, Lisa MS, Elizabeth TT, Jeannette RI: Measuring adherence among HIV-infected persons: Iis MEMS consummate technology?. AIDS and Behavior. 2001, 5: 21-30. 10.1023/A:1009503320498.CrossRef Jeffrey HS, Lisa MS, Elizabeth TT, Jeannette RI: Measuring adherence among HIV-infected persons: Iis MEMS consummate technology?. AIDS and Behavior. 2001, 5: 21-30. 10.1023/A:1009503320498.CrossRef
24.
go back to reference Byerly M, Fisher R, Whatley K, Holland R, Varghese F, Carmody T, Magouirk B, Rush AJ: A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Res. 2005, 133: 129-133. 10.1016/j.psychres.2004.11.002.CrossRefPubMed Byerly M, Fisher R, Whatley K, Holland R, Varghese F, Carmody T, Magouirk B, Rush AJ: A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Res. 2005, 133: 129-133. 10.1016/j.psychres.2004.11.002.CrossRefPubMed
Metadata
Title
Evaluation of medication adherence methods in the treatment of malaria in Rwandan infants
Authors
Marc Twagirumukiza
Pierre Claver Kayumba
Jan G Kips
Bernard Vrijens
Robert Vander Stichele
Chris Vervaet
Jean Paul Remon
M Luc Van Bortel
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2010
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-9-206

Other articles of this Issue 1/2010

Malaria Journal 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.